Dopaminergic correlates of metabolic network activity in Parkinson's disease

scientific article

Dopaminergic correlates of metabolic network activity in Parkinson's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HBM.22863
P932PMC publication ID6869564
P698PubMed publication ID26037537

P50authorLars TimmermannQ21043333
Gereon Rudolf FinkQ1511131
David EidelbergQ5233311
Carsten EggersQ108428565
Florian HoltberndQ66724680
L W KrachtQ67217650
P2093author name stringChris C Tang
Yilong Ma
Frank Schwartz
Shichun Peng
P2860cites workStriatal 18F-dopa uptake: absence of an aging effectQ72900520
???Q64786077
Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorderQ27303962
Staging of brain pathology related to sporadic Parkinson's diseaseQ28131702
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 casesQ29614910
Identification of disease-related spatial covariance patterns using neuroimaging dataQ30655192
Metabolic brain networks in neurodegenerative disorders: a functional imaging approachQ33504970
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issuesQ33726349
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's diseaseQ33835425
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomesQ34160461
Functional brain networks in movement disorders: recent advancesQ34308197
Changes in network activity with the progression of Parkinson's diseaseQ35679748
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.Q35683286
Metabolic brain networks associated with cognitive function in Parkinson's diseaseQ35684482
Anterior cingulate dopamine turnover and behavior change in Parkinson's diseaseQ35748883
Metabolic brain networks in translational neurology: concepts and applicationsQ36041821
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisQ36198606
Parkinson's disease cognitive network correlates with caudate dopamineQ36901626
Abnormal metabolic network activity in REM sleep behavior disorderQ37658353
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivoQ42467775
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's diseaseQ43281611
Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic studyQ44125048
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.Q44170628
Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in ParkinsonismQ44819125
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.Q44946964
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.Q46011395
High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's diseaseQ46331651
Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study.Q46549687
Metabolic correlates of subthalamic nucleus activity in Parkinson's diseaseQ46653986
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's diseaseQ46750528
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathwaysQ46848027
Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic functionQ48146679
Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageingQ48552859
[¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's diseaseQ48868532
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.Q48879551
Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.Q51160375
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study.Q51894202
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's diseaseQ57988220
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitryQ72144620
P433issue9
P921main subjectParkinson's diseaseQ11085
dopamineQ170304
metabolic networkQ2263094
P1104number of pages11
P304page(s)3575-3585
P577publication date2015-06-03
P1433published inHuman Brain MappingQ5936947
P1476titleDopaminergic correlates of metabolic network activity in Parkinson's disease
P478volume36

Reverse relations

cites work (P2860)
Q52099611Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
Q64967643Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography.
Q64780329Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder
Q91670190Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
Q39318829Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases
Q50629638Dynamic brain glucose metabolism identifies anti-correlated cortical-cerebellar networks at rest.
Q38666938FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
Q64806177FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis
Q37277039Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia
Q42488643Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
Q50091410Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia
Q47116959Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia
Q48674580Metabolic connectomics targeting brain pathology in dementia with Lewy bodies
Q31158920Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.
Q41492379Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns
Q47632627Network Structure and Function in Parkinson's Disease.
Q57178629Network imaging biomarkers: insights and clinical applications in Parkinson's disease
Q52317290New Imaging Markers for Movement Disorders.
Q57456370PET Imaging in Movement Disorders
Q64950011Preserved caudate function in young-onset patients with Parkinson's disease: a dual-tracer PET imaging study.

Search more.